Phenolic excipients of insulin formulations induce cell death, pro-inflammatory signaling and MCP-1 release.
作者:
关键词
APC, allophycocyaninAdverse effectsApidra (PubChem CID: 72941761)CCL2, chemokine ligand 2CD, cluster of differentiationCSII, continuous subcutaneous insulin infusionDMSO, dimethyl sulfoxideERK, extracellular signal-regulated kinaseHumalog (PubChem CID: 16132438)IL, interleukinIgG, immunoglobulin GInflammationInsulinInsulin (PubChem CID: 70678557)JNK, Jun N-terminal kinaseMAP kinase, mitogen-activated protein kinaseMCP-1MCP-1, monocyte chemotactic protein-1Mip-1α, macrophage inflammatory protein-1alphaNovoRapid (PubChem CID: 16132418)PE, phycoerythrinPhenol (PubChem CID: 996)Phenolic excipientsTNFα, tumor necrosis factor alphaXTT, 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilidem-Cresol (PubChem CID: 342)
DOI
10.1016/j.toxrep.2014.11.019
PMID
28962351
发布时间
2020-09-30
- 浏览6
Toxicology reports
2015年2卷
194-202页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文